A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of aliskiren, a novel direct rennin
inhibitor, on renal function and progress of renal disease in hypertensive patients with IgA
nephropathy.